When was NETRI founded?

NETRI was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is NETRI located?

NETRI is headquartered in Lyon, France.

Who is the current CEO of NETRI?

Thibault Honegger and Florian Larramendy s of NETRI. Thibault Honegger has also founded 1 company.

How many employees does NETRI have?

As of Sep 30, 2026, the latest employee count at NETRI is 44.

Is NETRI a funded company?

NETRI is a funded company, having raised a total of $14M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 03, 2022.

When was the latest funding round of NETRI?

NETRI's latest funding was a $***** Series A round on Feb 04, 2025, with participation from 0 investor.

Where does NETRI rank among its competitors?

NETRI ranks 10th amongst 55 active competitors, of which 21 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Emulate, which secured $493K in Sep, 2025.

Who are the top competitors of NETRI?

NETRI's top competitors include Mimetas, Emulate and CN Bio. Among them, Emulate secured the most recent funding round in September, 2025.

NETRI - 2026 Company Profile, Team, Funding, Competitors & Financials

NETRI is a series A company based in Lyon (France), founded in 2018 by Thibault Honegger and Florian Larramendy. It operates as a Developer of microfluidic devices for industrial applications. NETRI has raised $14M in funding. The company has 55 active competitors, including 21 funded and 2 that have exited. Its top competitors include companies like Mimetas, Emulate and CN Bio.

Company Details

Developer of microfluidic devices for industrial applications. The company has NeoBento a microfluidic platform that focuses on the development of next-generation 3D brain-on-a-chip models for the treatment of neurological diseases.

Website: netri.com
Social
Email ID: *****@netri.com
Phone Number: +33 **********

Key Metrics

Founded Year

2018

Location

Lyon, France

Stage

Series A

Total Funding

$14M in 2 rounds

Latest Funding Round

Series A, Feb 04, 2025, $*****

Investors

Bpifrance & 5 more

Ranked

10^th among 55 active competitors

Employee Count

44 as on Sep 30, 2026

Similar Companies

Mimetas & 56 more

View NETRI's full profile

NETRI is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Netri CIN: 840248744 , France, Deadpooled	Jun 11, 2018	-	-	-

NETRI has raised a total funding of $14M over 2 rounds. Its first funding round was on Mar 03, 2022. NETRI has 6 institutional investors.

Here is the list of recent funding rounds of NETRI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 04, 2025	9010163	Series A	5494076	2965830	2669385	6706411
Mar 03, 2022	7175200	Series A	2532981	1683858	9157475	Polygone & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of NETRI's funding rounds and investors

The founders of NETRI are Thibault Honegger and Florian Larramendy. Florian Larramendy and Thibault Honegger are the CEOs of NETRI.

Here are the details of NETRI's key team members:

Thibault Honegger: Co-Founder & CEO of NETRI and founder of 2 other companies, NETRI and Linkio.
Contact Info: 1 email address
Florian Larramendy: CEO - CTO - Co-founder of NETRI.

View details of NETRI's Founder profiles and Board Members

NETRI's employee count trend

NETRI has 44 employees as of Sep 26. Here is NETRI's employee count trend over the years:

Uncover NETRI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NETRI include Mimetas, Emulate and CN Bio. Here is the list of Top 10 competitors of NETRI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Mimetas 2013, Leiden (Netherlands), Acquired	Develops microfluidics-based organ-on-a-chip tissue models	$28.9M	Zeeuws Investerings Fonds, Oost NL & 13 others	60/100
2nd	Emulate 2013, Boston (United States), Series E	Developer of in vitro models for drug development	$204M	ND Capital, Cedars Sinai & 25 others	58/100
3rd	CN Bio 2009, Cambridge (United Kingdom), Series B	Develops organ-on-a-chip platforms for drug discovery	$71.2M	CITIC, Zray Management & 13 others	58/100
4th	Vivodyne 2021, Philadelphia (United States), Series A	Developer of AI-based platform for lab-grown human tissues	$80M	Khosla Ventures, MBX Capital & 6 others	53/100
5th	Hesperos 2015, Orlando (United States), Funding Raised	Developer of organ-on-a-chip solutions for preclinical testing	-	HHS, NCATS	53/100
6th	Obatala Sciences 2017, New Orleans (United States), Series A	Provider of research enabling products and services to research centers	$3.54M	Ochsner, être & 9 others	44/100
7th	Numa Biosciences 2007, Woodinville (United States), Acquired	Developer of platform for generating small segments of human tissues and organs in microfluidic chips	$10.7M	SeaChange Fund, Vertical Venture Partners ... & 3 others	43/100
8th	Okomera 2020, Paris (France), Seed	Developer of a device for in vitro cancer testing using a microfluidic chip	$11.2M	Resonance, Polytechnique Ventures & 4 others	42/100
9th	AxoSim 2014, New Orleans (United States), Series A	Engineering human brain and nerve models for neurological insights	$6.78M	Benson Capital Partners, Great Stuff Ventures ... & 9 others	40/100
10th	NETRI 2018, Lyon (France), Series A	Developer of microfluidic devices for industrial applications	$14M	Bpifrance, Netangels & 4 others	40/100